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Background: The widespread use of transesophageal echocardiography (TEE) is lim-
ited by disadvantages, including patient intolerance and increased medical costs.
We aimed to investigate the feasibility and safety of transnasal TEE in the detection
of possible embolic sources in patients with atrial ﬁbrillation (AF) and/or stroke,
using an ultrathin TEE probe.
Methods: Sixty-two patients with AF and/or stroke underwent transnasal TEE without
conscious sedation. The presence or the absence of the following parameters was
evaluated: left atrial (LA) thrombus; LA spontaneous echocardiographic contrast;
intraatrial shunts; and aortic plaque.
Results: The insertion of a TEE probe was successful in 52 (84%) patients. TEE found
LA thrombus in 10 (19%) patients and other embolic sources in 4 (8%) patients. Two
(4%) patients had mild epistaxis.
Conclusions: This study demonstrated that the use of transnasal TEE was feasible
and safe in the detection of LA thrombus in patients with AF and/or stroke.
© 2009 Japanese College of Cardiology. Published by Elsevier Ireland Ltd. All rights
reserved.
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The major complication of atrial ﬁbrillation (AF) is
thromboembolism. The left atrium (LA), especially
its appendage, is the presumed site of thrombus for-
mation and a source of arterial thromboembolism.
Previous studies suggested that up to 20% of all
strokes have been attributed to a cardioembolic
source, and patients with AF had a four- to ﬁve-
fold increased risk of stroke [1—3]. Transesophageal
echocardiography (TEE) has clear advantages over
transthoracic echocardiography (TTE) and other
imaging modalities in the detection of possible
embolic sources, particularly in the investigation of
the LA appendage [4—8]. Importantly, their diag-
nosis may have major therapeutic implications.
However, because of its disadvantages, including
patient intolerance and increased medical costs,
controversy exists in routinely performing TEE in
patients with AF and/or stroke [9—11].
In esophagogastroduodenoscopy, a transnasal
approach without conscious sedation has been
developed for various gastrointestinal condi-
tions. Compared with transoral esophagogastroduo-
denoscopy with sedation, similar or better patient
tolerance and acceptance with similar diagnostic
yields have been reported [12—14]. In addition,
the transoral approach potentially reduces the
procedure-related costs; direct costs of medica-
tions, and indirect costs associated with the need
for a second nurse/technician during the proce-
dure. The purpose of this study was therefore to
investigate the feasibility and safety of transnasal
TEE without sedation in the detection of LA throm-
bus and other possible embolic sources in patients




This study population consisted of 62 patients (36
males, mean age 71± 11 years) who had electro-
cardiographically documented AF (n = 49, 79%) or a
history of stroke diagnosed by magnetic resonance
imaging (n = 9, 15%), or both (n = 4, 6%). All patients
were referred to the laboratory for a clinically indi-
cated TEE examination because of normal results
on their TTE examination for possible intracardiac
sources of embolism. The patients were excluded
if they had (1) congenital disease, (2) a history of
nasopharyngeal trauma or surgery, or (3) allergy to
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ommittee of the Osaka Ekisaikai Hospital. Written
nformed consent for participation was obtained in
ll patients. We informed that the alternative was
standard transoral TEE if they chose not to par-
icipate in the study, if they did not tolerate the
xamination, or if imaging capabilities were inad-
quate to answer the referral questions in clinical
ractice.
nstrumentation
EE examination was performed with a Prosound
SD- 10 (Aloka Co, Ltd, Tokyo, Japan), equipped
ith an ultrathin probe, UST-52110S (Aloka Co,
td) (Fig. 1). This monoplane probe has single fre-
uency imaging (5.0MHz) as well as pulse-wave
oppler and color Doppler capabilities. The tip size
f the phased array transducer was 6.0mm wide,
.3mm thick, and 13.4mm long. The probe shaft
as 4.8mm in diameter, and the probe was 70 cm
n length. The probe was equipped with an anteﬂex-
on and retroﬂexion angulation control via a knob on
he handle. This probe was originally released for
EE examination via a transoral approach in pedi-
tric patients in whom standard size probes could
ot be used.
reparation and insertion
reparation for nasal TEE included topical anes-
hesia of the nasal passage. The nasal cavity was
prayed with 0.05% naphazoline nitrate for vaso-
onstriction. A few minutes later, lidocaine jelly
as spread on a 12-Fr soft plastic conduit, which
as inserted in the nasal cavity, followed by a 16-
r conduit. The aims of inserting the 12-Fr and 16-Fr
lastic conduits were local anesthesia of the nasal
avity and to prevent rhinostenosis. The diameter
f 16-Fr plastic conduit was almost equal to that of
he TEE probe. At the time of 12-Fr and 16-Fr plastic
onduit insertion into the nasal cavity, we exam-
ned the resistance of the insertion and decided
hich nasal cavity was easier to insert the probe.
t was also conﬁrmed that the patient experienced
o pain. It took approximately 15min to provide
ufﬁcient topical anesthesia of the transnasal TEE.
The probe was introduced into the nares and
dvanced through the nasal cavity, as previously
escribed [15,16]. On reaching the posterior nasal
avity, mild anteﬂexion was applied, and the probe
as passed through the nasopharynx. At the level
f the oropharynx, the anteﬂexion was released,
nd the probe was directed into the esophagus
ith gentle forward pressure. Immediately after
he procedure, patients were asked to reply regard-

















































as judged using four ranks, from well tolerated
o mild, moderate, or severe discomfort. Tolerance
uring the probe insertion was evaluated in two
eparate phases, passage of nasal cavity and esoph-
gus, respectively. It was judged by three ranks of
o pain, discomfort without pain, and discomfort
ith pain.
EE assessment
he presence or the absence of thrombus in
he LA and its appendage was evaluated in the
resent study. Spontaneous echocardiographic con-
rast in the atrium, intraatrial shunts, atrial septal
neurysm, and aortic plaque were also assessed as
ossible sources of embolism. Thrombus was diag-
osed as an echo dense mass with independent
otion relative to the chamber wall. Spontaneous
chocardiographic contrast was deﬁned as dynamic
‘smoke-like’’ echoes in the atrium. Gain settings
ere adjusted to minimize gray-noise artifact when
ssessing for spontaneous echocardiographic con-
rast. The LA appendage ﬂow velocity was obtained
y the pulsed Doppler method with the sample vol-
me placed 1 cm distal from the mouth of the LA
ppendage. Five consecutive cardiac cycles were
ecorded and averaged. Intraatrial shunts, atrial
eptal aneurysm, and aortic plaque were evaluated





igure 1 Frontal (A) and lateral (B) views of the ultrathin
ransesophageal echocardiography probes are shown for com
4.6mm wide, 5.3 and 11.8mm thick, 13.4 and 24mm long, an427
he success or failure of the procedure, the rea-
on for failure, and the adverse effects of the TEE
xamination.
tatistical analysis
alues were expressed as mean± SD. Comparisons
etween the two groups for the parametric data
ere made with an unpaired t test. Differences
ere considered signiﬁcant at P < 0.05.
esults
nsertion of TEE probe through nasal cavity
he insertion of the TEE probe was successfully
ompleted in 52 (84%) of 62 patients. Failed inser-
ion was caused by anatomical reasons (failure to
ass the probe through the nasal cavity) in 8 (13%)
atients and patient intolerance (pain) in 2 (3%)
atients. These 10 patients did not have epistaxis.
o examinations were failed due to inability to pass
he probe into the esophagus. The clinical charac-
eristics of patients with success or failure of the
robe insertion are summarized in Table 1. There
ere no signiﬁcant differences in patient charac-
eristics.
(UST-52110S, left) and conventional (UST-5293S, right)
parison. The tip sizes of the transducers were 6.0 and
d the shaft diameters were 4.8 and 9.0mm, respectively.
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Table 1 Characteristics of patients with success or failure of the insertion of transesophageal echocardiography
probe.
Success (n = 52) Failure (n = 10) P-value
Age (years) 71± 10 64± 14 0.1
Gender, male (n, %) 27 (61%) 5 (63%) 0.6
Weight (kg) 59.0± 14.3 63.9± 13.3 0.4
Height (m) 160.0± 9.5 165.6± 8.3 0.1
Body surface area (m2) 1.6± 0.2 1.7± 0.2 0.2
History of inﬂammatory disease in nasopharynx (n, %) 4 (9%) 3 (38%) 0.3
Underlying etiology
AF (n, %) 36 (82%) 8 (100%) 0.2
Stroke (n, %) 10 (23%) 0 (0%) 0.2
Medication









insertion into nasal cavity and esophagus, respec-Aspirin (n, %)
AF, atrial ﬁbrillation.
Echocardiographic ﬁndings
Among 52 patients, transnasal TEE found at least
one potential intracardiac source of embolism in 14
(27%) patients; LA appendage thrombus with spon-
taneous echocardiographic contrast in 7 patients
and without spontaneous echocardiographic con-
trast in 3 patients, spontaneous echocardiographic
contrast without the thrombus in 2 patients,
patent foramen ovale in 1 patient, and mobile
aortic plaque in 1 patient. Fig. 2 shows an
example of thrombus in the LA appendage. LA
appendage ﬂow velocity was measured in 48
(92%) patients. Patients with LA thrombus and/or
spontaneous echocardiographic contrast had lower




Figure 2 (A) Transesophageal echocardiography image focu
atrial ﬁbrillation (AF). A mobile thrombus was detected in t
measured at the outlet of the appendage, showing low LA ap14 (53%) 4 (50%) 0.3
ng patients (12.7± 5.3 cm/s vs 33.4± 18.8 cm/s,
< 0.001).
olerance and safety of transnasal TEE
he questionnaire regarding tolerance was com-
leted by 50 (96%) of 52 patients. Twenty-nine
58%) patients answered ‘‘well tolerated’’ for top-
cal anesthesia (Fig. 3). ‘‘No pain/discomfort’’ was
eported by 36 (72%) and 42 (84%) patients for theively (Fig. 3).
In 52 patients, the oral administration of war-
arin was observed in 29 (56%) patients, and
spirin in 18 (35%) patients. Two (4%) patients
sing on the left atrium (LA) appendage in patients with
he appendage (arrows). (B) Pulse-wave Doppler image
pendage emptying and ﬁlling Doppler signals.














































































pigure 3 The results of questionnaire regarding the tole
avity (B), and esophagus (C), respectively.
ad mild epistaxis after the procedure. This epis-
axis stopped spontaneously within 3min. These
atients had warfarin therapy without aspirin at
he time of procedure, where the values of pro-
hrombin time—international normalized ratio were
.45 and 1.85 s, respectively. No signiﬁcant hemo-
ynamic or mechanical complications were noted
uring procedure or follow-up. Also, there were no
omplications for topical anesthesia with the use of
asoconstrictor.
iscussion
his study demonstrated that transnasal TEE with-
ut conscious sedation was feasible (85%) and safe
n the detection of LA thrombus in patients with AF
nd/or stroke.
The advantages of TEE over TTE and other
maging modalities for detecting possible embolic
ources have been clearly described, particularly in
he investigation of the LA appendage [4,5]. Nev-
rtheless, whether TEE should be performed in all
atients with AF and/or stroke remains a matter of
ebate [9—11]. The guideline also concluded that
he use of TEE in a patient with stroke who had a
ormal TTE and no history of AF in the detection
f embolic sources was uncertain [17]. One prob-
em of current TEE technique is the large size of
he probe, which causes discomfort during entry
nto the esophagus, requiring moderate levels of
onscious sedation. Close monitoring during and
fter the procedure, as well as specialized nursing
are, are therefore needed. These efforts result in
atient intolerance as well as increasing medical
osts; direct costs of intravenous access and med-
cations, indirect costs associated with the need
or a second nurse/technician during the proce-
ure, and direct non-health costs for time-loss from
ork for both patient and patient’s escort. Also,
onscious sedation may cause drug-induced respira-




ce for topical anesthesia (A), and the insertion into nasal
r arrhythmia in up to 0.5% to 2.0% of the proce-
ures [18,19]. To overcome these limitations, there
s a need for safe and feasible TEE techniques, even
ithout conscious sedation.
The transnasal approach without conscious seda-
ion is widely used for various gastrointestinal
onditions in the esophagogastroduodenoscopy,
specially in Asian and European countries [20,21].
he transnasal approach has less gagging, but the
atient experiences more pain on insertion of
he endoscope, as compared with the transoral
pproach. Therefore, sufﬁcient nasal anesthe-
ia and a small size of endoscope are vital
or transnasal esophagogastroduodenoscopy. Previ-
us studies demonstrated that the feasibility and
he tolerance of transnasal esophagogastroduo-
enoscopy without conscious sedation were related
o the endoscope diameter [22,23]. Murata et al.
ho used a 5.9mm endoscope reported that the
ransnasal approach was well tolerated and con-
iderably reduced patient discomfort as compared
ith the transoral approach [24]. In the ﬁeld of
EE, Spencer et al. demonstrated that transnasal
ntubation of a TEE probe was feasible and safe in
atients with various heart diseases [15,16]. How-
ver, their patients required conscious sedation
uring the procedure due to the relatively large
EE probe (7.3mm wide and 6.0mm thick). In the
resent study, the use of an ultrathin probe (6.0mm
ide and 5.3mm thick) allowed for a transnasal
pproach using topical anesthesia. Approximately
0% of patients answered ‘‘no pain/discomfort’’
or the probe insertion passing through the nasal
avity and esophagus with sufﬁcient topical anes-
hesia only without conscious sedation. In addition,
he cost—effectiveness of an unsedated procedure
as clearly described in the esophagogastroduo-
enoscopy. The cost of a conventional sedated
rocedure was reduced by 35—60% in the unse-
ated procedure [12,25]. As a consequence, we
elieve that transnasal TEE without conscious seda-
ion using an ultrathin probe is safe, feasible and













TEE in clinical practice, similar to the esopha-
gogastroduodenoscopy. The widespread use of TEE
would help to clarify the effectiveness of TEE
in the management and the outcome among the
patients with and without TEE examination in AF
and/stroke.
Study limitations
There were several limitations to this study. First,
there were no signiﬁcant differences in patient
characteristics between patients with success or
failure of the insertion of TEE probe. It might be
explained by the small number of patients. In addi-
tion, only 1 patient had patent foramen ovale, and
1 patient had mobile aortic plaque. Therefore, fur-
ther studies with a larger number of patients should
be necessary.
Second, validation against the standard tech-
nique was not performed. The feasibility and safety
of the transnasal approach should be compared
with those of routine transoral TEE performance
in future investigations. Two patients taking war-
farin had epistaxis (nasal bleeding). This bleeding
may be an issue in the wide use of TEE in clinical
practice. In addition, criteria of tolerance rank-
ing were subjective and semi-quantitative in the
present study. Also, we cannot eliminate the pos-
sibility of the underestimation of the presence of
thrombus. This thin probe potentially has poor con-
tact with the esophageal wall in an adult subject.
However, the prevalence of LA thrombus of 19% in
our study was similar to that reported in previous
investigations [26,27]. A future miniature omni-
plane probe with better image quality should be
developed.
Third, the transnasal unsedated approach
required familiarity with nasal and pharyngeal
anatomies and expertise with transnasal intubation
and nasopharyngeal advancement of the probe.
The supervision or structured training provided
by expert endoscopists might be needed with the
initial attempts.
Finally, the cost of intravenous access and
medications was 500—1500 yen per sedated TEE
examination in Japan, depending on the sedative
agents. Such direct medical cost was dispensable
in the unsedated procedure. However, the 12-Fr
and 16-Fr plastic conduits were necessary only for
the transnasal approach. This cost should be evalu-
ated without excluding patients unable to complete
transnasal TEE. Also, cost—effectiveness associated
with indirect and direct non-health costs was not
assessed in this study. Further investigation might
be necessary to clarify this point.
[S. Fukuda et al.
onclusion
his study demonstrated that transnasal TEE with-
ut conscious sedation was safe and feasible (84%)
n the detection of LA thrombus in patients with
F and/or stroke, using an ultrathin TEE probe.
his approach has the potential to enhance the
se of TEE in clinical practice, providing reduced
rocedure-related costs with similar or better
atient tolerance.
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